Effect of roxadustat on lowering blood lipids in peritoneal dialysis patients with anemia
Objectives To observe the effect of roxadustat on lowering blood lipids in peritoneal dialysis (PD) patients beyond treating anemia.Methods In a prospective, multicenter clinical study, we randomly assigned (in a 1:1 ratio) 100 PD patients who had received erythropoiesis-stimulating agent therapy fo...
Saved in:
| Main Authors: | Tian Xu, Yilin Ruan, Na Liu, Yi Wang, Xiujuan Zang, Yuhua Ma, Hualin Qi, Xiuhua Mi, Geping Yu, Chunyan Zhang, Xiaomin Huang, Jingyuan Xie, Nan Chen, Hong Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2460726 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
by: Qiaoqiao Zhou, et al.
Published: (2023-12-01) -
Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia
by: Ping Li, et al.
Published: (2025-04-01) -
Comparison of anemia in elderly patients with peritoneal dialysis and hemodialysis
by: CHENG Li, et al.
Published: (2018-01-01) -
Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients
by: Kenta Torigoe, et al.
Published: (2025-04-01) -
Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
by: Wenhui Wu, et al.
Published: (2024-12-01)